User contributions for Michaelagibson
Jump to navigation
Jump to search
29 June 2009
- 15:1315:13, 29 June 2009 diff hist +98 N BENEFIT ←Redirected page to Betaferon (Betaseron In U.S.) In Newly Emerging Ms For Initial Treatment Information current
- 15:1215:12, 29 June 2009 diff hist +99 N BENEFiT ←Redirected page to Bosentan Effects In Inoperable Forms Of Chronic Thromboembolic Pulmonary Hypertension current
- 15:1115:11, 29 June 2009 diff hist +61 N BENEDICT ←Redirected page to Bergamo Nephrologic Diabetes Complications Tria current
- 15:1015:10, 29 June 2009 diff hist +62 N BELLES ←Redirected page to Beyond Endorsed Lipid Lowering With Ebt Scanning current
- 15:1015:10, 29 June 2009 diff hist −73 Acronyms of Clinical Trial Names No edit summary
- 15:0915:09, 29 June 2009 diff hist +69 N BECAIT ←Redirected page to Bezafibrate Coronary Atherosclerosis Intervention Trial current
- 15:0815:08, 29 June 2009 diff hist +142 N BEAUTIFUL ←Redirected page to Morbidity-Mortality Evaluation Of The If Inhibitor Ivabradine In Patients With Coronary Disease And Left-Ventricular Dysfunction current
- 15:0815:08, 29 June 2009 diff hist +72 N BEAT ←Redirected page to Bucindolol Evaluation In Acute Myocardial Infarction Trial current
- 15:0815:08, 29 June 2009 diff hist +93 N BEACH ←Redirected page to Boston Scientific Epi: A Carotid Stenting Trial For High-Risk Surgical Patients current
- 15:0715:07, 29 June 2009 diff hist +44 N BCPT ←Redirected page to Breast Cancer Prevention Trial current
- 15:0615:06, 29 June 2009 diff hist +73 N BCAPS ←Redirected page to Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study current
- 15:0515:05, 29 June 2009 diff hist +2 ASSENT 3 PLUS ←Redirected page to Assessment Of The Safety And Efficacy Of A New Thrombolytic Regimen-3
- 15:0515:05, 29 June 2009 diff hist +111 N ASSENT-4 PCI ←Redirected page to Assessment Of The Safety And Efficacy Of A New Treatment Strategy For Acute Myocardial Infarction
- 15:0415:04, 29 June 2009 diff hist +84 N ASSENT-2 ←Redirected page to Assessment Of The Safety And Efficacy Of A New Thrombolytic: Tnk-Tpa-2
- 15:0315:03, 29 June 2009 diff hist +17 Acronyms of Clinical Trial Names No edit summary
- 15:0115:01, 29 June 2009 diff hist +69 N ASSENT-1 ←Redirected page to Assessment Of The Safety Of A New Thrombolytic: Tnk-Tpa
- 15:0115:01, 29 June 2009 diff hist +81 N ASSENT 3 PLUS ←Redirected page to Assessment Of The Safety And Efficacy Of A New Thrombolytic Regimen
- 15:0015:00, 29 June 2009 diff hist +259 N ASSENT 3 ←Redirected page to [[The Assessment Of The Safety And Efficacy Of A New Thrombolytic Regimen (Assent)-3 Investigators. Efficacy And Safety Of Tenecteplase In Combination With Enoxaparin, Abciximab, Or Unfractionated Heparin: The Assent-3 Ran current
- 14:5914:59, 29 June 2009 diff hist −83 Acronyms of Clinical Trial Names No edit summary
- 14:5614:56, 29 June 2009 diff hist +95 N ARMYDA-RELOAD ←Redirected page to Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty-Reload